AMYRIS INC (AMRS) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:AMRS • US03236M2008

0.05 USD
-0.01 (-21.87%)
At close: Aug 18, 2023
0.052 USD
+0 (+4%)
After Hours: 8/18/2023, 8:19:54 PM
Fundamental Rating

1

Taking everything into account, AMRS scores 1 out of 10 in our fundamental rating. AMRS was compared to 83 industry peers in the Chemicals industry. AMRS has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, AMRS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AMRS has reported negative net income.
  • AMRS had a negative operating cash flow in the past year.
AMRS Yearly Net Income VS EBIT VS OCF VS FCFAMRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -200M -400M -600M

1.2 Ratios

  • The profitability ratios for AMRS are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMRS Yearly ROA, ROE, ROICAMRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 20K 40K 60K 80K

1.3 Margins

  • Looking at the Gross Margin, with a value of 3.38%, AMRS is doing worse than 87.36% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AMRS has declined.
  • AMRS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.8%
GM growth 5Y-38.18%
AMRS Yearly Profit, Operating, Gross MarginsAMRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 -100 -200 -300

More info and screens

0

2. Health

2.1 Basic Checks

  • AMRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, AMRS has more shares outstanding
  • AMRS has a worse debt/assets ratio than last year.
AMRS Yearly Shares OutstandingAMRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M
AMRS Yearly Total Debt VS Total AssetsAMRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

  • AMRS has an Altman-Z score of -9.17. This is a bad value and indicates that AMRS is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -9.17, AMRS is doing worse than 90.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.17
ROIC/WACCN/A
WACC1.72%
AMRS Yearly LT Debt VS Equity VS FCFAMRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 500M -500M

2.3 Liquidity

  • AMRS has a Current Ratio of 0.52. This is a bad value and indicates that AMRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.52, AMRS is not doing good in the industry: 94.25% of the companies in the same industry are doing better.
  • AMRS has a Quick Ratio of 0.52. This is a bad value and indicates that AMRS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AMRS has a Quick ratio of 0.29. This is amonst the worse of the industry: AMRS underperforms 95.40% of its industry peers.
Industry RankSector Rank
Current Ratio 0.52
Quick Ratio 0.29
AMRS Yearly Current Assets VS Current LiabilitesAMRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

  • AMRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -595.83%.
  • Looking at the last year, AMRS shows a very negative growth in Revenue. The Revenue has decreased by -32.87% in the last year.
  • The Revenue has been growing by 16.14% on average over the past years. This is quite good.
EPS 1Y (TTM)-595.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.94%
Revenue 1Y (TTM)-32.87%
Revenue growth 3Y20.93%
Revenue growth 5Y16.14%
Sales Q2Q%-2.82%

3.2 Future

  • The Earnings Per Share is expected to grow by 22.70% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, AMRS will show a very strong growth in Revenue. The Revenue will grow by 21.11% on average per year.
EPS Next Y67.21%
EPS Next 2Y30.71%
EPS Next 3Y22.7%
EPS Next 5YN/A
Revenue Next Year76.61%
Revenue Next 2Y27.5%
Revenue Next 3Y26.8%
Revenue Next 5Y21.11%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AMRS Yearly Revenue VS EstimatesAMRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B
AMRS Yearly EPS VS EstimatesAMRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5 -10 -15 -20 -25

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AMRS. In the last year negative earnings were reported.
  • Also next year AMRS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMRS Price Earnings VS Forward Price EarningsAMRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMRS Per share dataAMRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • AMRS's earnings are expected to grow with 22.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.71%
EPS Next 3Y22.7%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for AMRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMYRIS INC

NASDAQ:AMRS (8/18/2023, 8:19:54 PM)

After market: 0.052 +0 (+4%)

0.05

-0.01 (-21.87%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-09
Earnings (Next)11-06
Inst Owners0%
Inst Owner Change-99.37%
Ins Owners4.57%
Ins Owner Change0%
Market Cap18.47M
Revenue(TTM)268.22M
Net Income(TTM)-614.55M
Analysts72.86
Price Target1.74 (3380%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.44%
Min EPS beat(2)-80.22%
Max EPS beat(2)-0.65%
EPS beat(4)0
Avg EPS beat(4)-60.02%
Min EPS beat(4)-133.43%
Max EPS beat(4)-0.65%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-12.47%
Min Revenue beat(2)-28.61%
Max Revenue beat(2)3.67%
Revenue beat(4)1
Avg Revenue beat(4)-17.51%
Min Revenue beat(4)-28.61%
Max Revenue beat(4)3.67%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-9.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.67
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.46
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS0.73
BVpS-1.8
TBVpS-2.06
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.38%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-54.8%
GM growth 5Y-38.18%
F-Score1
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 397.44%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.52
Quick Ratio 0.29
Altman-Z -9.17
F-Score1
WACC1.72%
ROIC/WACCN/A
Cap/Depr(3y)411.87%
Cap/Depr(5y)354.93%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-595.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.94%
EPS Next Y67.21%
EPS Next 2Y30.71%
EPS Next 3Y22.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-32.87%
Revenue growth 3Y20.93%
Revenue growth 5Y16.14%
Sales Q2Q%-2.82%
Revenue Next Year76.61%
Revenue Next 2Y27.5%
Revenue Next 3Y26.8%
Revenue Next 5Y21.11%
EBIT growth 1Y-101.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year70.73%
EBIT Next 3Y23.52%
EBIT Next 5YN/A
FCF growth 1Y-1444.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2138.9%
OCF growth 3YN/A
OCF growth 5YN/A

AMYRIS INC / AMRS FAQ

What is the fundamental rating for AMRS stock?

ChartMill assigns a fundamental rating of 1 / 10 to AMRS.


What is the valuation status of AMYRIS INC (AMRS) stock?

ChartMill assigns a valuation rating of 1 / 10 to AMYRIS INC (AMRS). This can be considered as Overvalued.


How profitable is AMYRIS INC (AMRS) stock?

AMYRIS INC (AMRS) has a profitability rating of 0 / 10.


Can you provide the financial health for AMRS stock?

The financial health rating of AMYRIS INC (AMRS) is 0 / 10.